Breedlove Robert Charles bought PHAT
February 27, 2026 · Form 4 insider transaction
Breedlove Robert Charles bought 2,790 shares of Phathom Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,790
Price
$0.00
Total value
N/A
InsiderBreedlove Robert Charles
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 27, 2026
Filing dateMarch 3, 2026
Shares owned after62,858
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares issued upon vesting of performance stock units granted to the reporting person on February 27, 2025 based on the achievement of performance criteria determined to be satisfied on February 27, 2026.